Global New Chemical Entities (NCE) Market growth is projected to reach USD $ Billion in 2025, at a $% CAGR by driving industry size, share, segments research, top company analysis, trends and forecast report 2025 to 2031.

Global New Chemical Entities (NCE) Market Trends and Outlook 2025-31

The global New Chemical Entities (NCE) market size is predicted to grow from US$ 4435 million in 2025 to US$ 8595 million in 2031; it is expected to grow at a CAGR of 11.7% from 2025 to 2031. During the drug discovery process, new compounds or active moieties (molecules or ions responsible for physiological or pharmacological action) can arise that have not previously been FDA-approved. These compounds are called New Chemical Entities (NCE) as they have not previously been used, and they can help bring about cures and therapies for incurable diseases such as cancer due to the novelty of the drug and or compound.In the existing market, there are already companies providing CDMO services for new chemical entities, and there are also companies providing new chemical entity discovery services, which can then be handed over to other companies for drug development. United States market for New Chemical Entities (NCE) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for New Chemical Entities (NCE) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for New Chemical Entities (NCE) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key New Chemical Entities (NCE) players cover KATSURA CHEMICAL CO., LTD, NMS Group (Accelera Srl), Adragos Pharma, Syngene, Regis Custom API, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. LPI (LP Information) newest research report, the ?New Chemical Entities (NCE) Industry Forecast? looks at past sales and reviews total world New Chemical Entities (NCE) sales in 2024, providing a comprehensive analysis by region and market sector of projected New Chemical Entities (NCE) sales for 2025 through 2031. With New Chemical Entities (NCE) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world New Chemical Entities (NCE) industry. This Insight Report provides a comprehensive analysis of the global New Chemical Entities (NCE) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on New Chemical Entities (NCE) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global New Chemical Entities (NCE) market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for New Chemical Entities (NCE) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global New Chemical Entities (NCE). This report presents a comprehensive overview, market shares, and growth opportunities of New Chemical Entities (NCE) market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; NCE Discovery &nbsp;&nbsp;&nbsp; Drug Formulation Development &nbsp;&nbsp;&nbsp; Large-scale Manufacturing Segmentation by Application: &nbsp;&nbsp;&nbsp; Tumors &nbsp;&nbsp;&nbsp; Cardiovascular Diseases &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; KATSURA CHEMICAL CO., LTD &nbsp;&nbsp;&nbsp; NMS Group (Accelera Srl) &nbsp;&nbsp;&nbsp; Adragos Pharma &nbsp;&nbsp;&nbsp; Syngene &nbsp;&nbsp;&nbsp; Regis Custom API &nbsp;&nbsp;&nbsp; Bachem &nbsp;&nbsp;&nbsp; Suven Pharma &nbsp;&nbsp;&nbsp; Aspen API &nbsp;&nbsp;&nbsp; MedPharm &nbsp;&nbsp;&nbsp; Intertek &nbsp;&nbsp;&nbsp; Neuland Laboratories &nbsp;&nbsp;&nbsp; Piramal Pharma Solutions &nbsp;&nbsp;&nbsp; Sai Life Sciences &nbsp;&nbsp;&nbsp; Chempro Pharma &nbsp;&nbsp;&nbsp; LG Chem &nbsp;&nbsp;&nbsp; Sofpromed &nbsp;&nbsp;&nbsp; Aurigene Pharmaceutical Services Ltd. &nbsp;&nbsp;&nbsp; Aragen Life Sciences Ltd &nbsp;&nbsp;&nbsp; WuXi AppTec &nbsp;&nbsp;&nbsp; PharmaBlock Sciences Nanjing Inc

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global New Chemical Entities (NCE) Market Size (2020-2031) &nbsp;2.1.2 New Chemical Entities (NCE) Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for New Chemical Entities (NCE) by Country/Region (2020, 2024 & 2031) &nbsp;2.2 New Chemical Entities (NCE) Segment by Type &nbsp;2.2.1 NCE Discovery &nbsp;2.2.2 Drug Formulation Development &nbsp;2.2.3 Large-scale Manufacturing &nbsp;2.3 New Chemical Entities (NCE) Market Size by Type &nbsp;2.3.1 New Chemical Entities (NCE) Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global New Chemical Entities (NCE) Market Size Market Share by Type (2020-2025) &nbsp;2.4 New Chemical Entities (NCE) Segment by Application &nbsp;2.4.1 Tumors &nbsp;2.4.2 Cardiovascular Diseases &nbsp;2.4.3 Other &nbsp;2.5 New Chemical Entities (NCE) Market Size by Application &nbsp;2.5.1 New Chemical Entities (NCE) Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global New Chemical Entities (NCE) Market Size Market Share by Application (2020-2025) 3 New Chemical Entities (NCE) Market Size by Player &nbsp;3.1 New Chemical Entities (NCE) Market Size Market Share by Player &nbsp;3.1.1 Global New Chemical Entities (NCE) Revenue by Player (2020-2025) &nbsp;3.1.2 Global New Chemical Entities (NCE) Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global New Chemical Entities (NCE) Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 New Chemical Entities (NCE) by Region &nbsp;4.1 New Chemical Entities (NCE) Market Size by Region (2020-2025) &nbsp;4.2 Global New Chemical Entities (NCE) Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas New Chemical Entities (NCE) Market Size Growth (2020-2025) &nbsp;4.4 APAC New Chemical Entities (NCE) Market Size Growth (2020-2025) &nbsp;4.5 Europe New Chemical Entities (NCE) Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa New Chemical Entities (NCE) Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas New Chemical Entities (NCE) Market Size by Country (2020-2025) &nbsp;5.2 Americas New Chemical Entities (NCE) Market Size by Type (2020-2025) &nbsp;5.3 Americas New Chemical Entities (NCE) Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC New Chemical Entities (NCE) Market Size by Region (2020-2025) &nbsp;6.2 APAC New Chemical Entities (NCE) Market Size by Type (2020-2025) &nbsp;6.3 APAC New Chemical Entities (NCE) Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe New Chemical Entities (NCE) Market Size by Country (2020-2025) &nbsp;7.2 Europe New Chemical Entities (NCE) Market Size by Type (2020-2025) &nbsp;7.3 Europe New Chemical Entities (NCE) Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa New Chemical Entities (NCE) by Region (2020-2025) &nbsp;8.2 Middle East & Africa New Chemical Entities (NCE) Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa New Chemical Entities (NCE) Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global New Chemical Entities (NCE) Market Forecast &nbsp;10.1 Global New Chemical Entities (NCE) Forecast by Region (2026-2031) &nbsp;10.1.1 Global New Chemical Entities (NCE) Forecast by Region (2026-2031) &nbsp;10.1.2 Americas New Chemical Entities (NCE) Forecast &nbsp;10.1.3 APAC New Chemical Entities (NCE) Forecast &nbsp;10.1.4 Europe New Chemical Entities (NCE) Forecast &nbsp;10.1.5 Middle East & Africa New Chemical Entities (NCE) Forecast &nbsp;10.2 Americas New Chemical Entities (NCE) Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market New Chemical Entities (NCE) Forecast &nbsp;10.2.2 Canada Market New Chemical Entities (NCE) Forecast &nbsp;10.2.3 Mexico Market New Chemical Entities (NCE) Forecast &nbsp;10.2.4 Brazil Market New Chemical Entities (NCE) Forecast &nbsp;10.3 APAC New Chemical Entities (NCE) Forecast by Region (2026-2031) &nbsp;10.3.1 China New Chemical Entities (NCE) Market Forecast &nbsp;10.3.2 Japan Market New Chemical Entities (NCE) Forecast &nbsp;10.3.3 Korea Market New Chemical Entities (NCE) Forecast &nbsp;10.3.4 Southeast Asia Market New Chemical Entities (NCE) Forecast &nbsp;10.3.5 India Market New Chemical Entities (NCE) Forecast &nbsp;10.3.6 Australia Market New Chemical Entities (NCE) Forecast &nbsp;10.4 Europe New Chemical Entities (NCE) Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market New Chemical Entities (NCE) Forecast &nbsp;10.4.2 France Market New Chemical Entities (NCE) Forecast &nbsp;10.4.3 UK Market New Chemical Entities (NCE) Forecast &nbsp;10.4.4 Italy Market New Chemical Entities (NCE) Forecast &nbsp;10.4.5 Russia Market New Chemical Entities (NCE) Forecast &nbsp;10.5 Middle East & Africa New Chemical Entities (NCE) Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market New Chemical Entities (NCE) Forecast &nbsp;10.5.2 South Africa Market New Chemical Entities (NCE) Forecast &nbsp;10.5.3 Israel Market New Chemical Entities (NCE) Forecast &nbsp;10.5.4 Turkey Market New Chemical Entities (NCE) Forecast &nbsp;10.6 Global New Chemical Entities (NCE) Forecast by Type (2026-2031) &nbsp;10.7 Global New Chemical Entities (NCE) Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market New Chemical Entities (NCE) Forecast 11 Key Players Analysis &nbsp;11.1 KATSURA CHEMICAL CO., LTD &nbsp;11.1.1 KATSURA CHEMICAL CO., LTD Company Information &nbsp;11.1.2 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) Product Offered &nbsp;11.1.3 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 KATSURA CHEMICAL CO., LTD Main Business Overview &nbsp;11.1.5 KATSURA CHEMICAL CO., LTD Latest Developments &nbsp;11.2 NMS Group (Accelera Srl) &nbsp;11.2.1 NMS Group (Accelera Srl) Company Information &nbsp;11.2.2 NMS Group (Accelera Srl) New Chemical Entities (NCE) Product Offered &nbsp;11.2.3 NMS Group (Accelera Srl) New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 NMS Group (Accelera Srl) Main Business Overview &nbsp;11.2.5 NMS Group (Accelera Srl) Latest Developments &nbsp;11.3 Adragos Pharma &nbsp;11.3.1 Adragos Pharma Company Information &nbsp;11.3.2 Adragos Pharma New Chemical Entities (NCE) Product Offered &nbsp;11.3.3 Adragos Pharma New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Adragos Pharma Main Business Overview &nbsp;11.3.5 Adragos Pharma Latest Developments &nbsp;11.4 Syngene &nbsp;11.4.1 Syngene Company Information &nbsp;11.4.2 Syngene New Chemical Entities (NCE) Product Offered &nbsp;11.4.3 Syngene New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Syngene Main Business Overview &nbsp;11.4.5 Syngene Latest Developments &nbsp;11.5 Regis Custom API &nbsp;11.5.1 Regis Custom API Company Information &nbsp;11.5.2 Regis Custom API New Chemical Entities (NCE) Product Offered &nbsp;11.5.3 Regis Custom API New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Regis Custom API Main Business Overview &nbsp;11.5.5 Regis Custom API Latest Developments &nbsp;11.6 Bachem &nbsp;11.6.1 Bachem Company Information &nbsp;11.6.2 Bachem New Chemical Entities (NCE) Product Offered &nbsp;11.6.3 Bachem New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Bachem Main Business Overview &nbsp;11.6.5 Bachem Latest Developments &nbsp;11.7 Suven Pharma &nbsp;11.7.1 Suven Pharma Company Information &nbsp;11.7.2 Suven Pharma New Chemical Entities (NCE) Product Offered &nbsp;11.7.3 Suven Pharma New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Suven Pharma Main Business Overview &nbsp;11.7.5 Suven Pharma Latest Developments &nbsp;11.8 Aspen API &nbsp;11.8.1 Aspen API Company Information &nbsp;11.8.2 Aspen API New Chemical Entities (NCE) Product Offered &nbsp;11.8.3 Aspen API New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Aspen API Main Business Overview &nbsp;11.8.5 Aspen API Latest Developments &nbsp;11.9 MedPharm &nbsp;11.9.1 MedPharm Company Information &nbsp;11.9.2 MedPharm New Chemical Entities (NCE) Product Offered &nbsp;11.9.3 MedPharm New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 MedPharm Main Business Overview &nbsp;11.9.5 MedPharm Latest Developments &nbsp;11.10 Intertek &nbsp;11.10.1 Intertek Company Information &nbsp;11.10.2 Intertek New Chemical Entities (NCE) Product Offered &nbsp;11.10.3 Intertek New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Intertek Main Business Overview &nbsp;11.10.5 Intertek Latest Developments &nbsp;11.11 Neuland Laboratories &nbsp;11.11.1 Neuland Laboratories Company Information &nbsp;11.11.2 Neuland Laboratories New Chemical Entities (NCE) Product Offered &nbsp;11.11.3 Neuland Laboratories New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 Neuland Laboratories Main Business Overview &nbsp;11.11.5 Neuland Laboratories Latest Developments &nbsp;11.12 Piramal Pharma Solutions &nbsp;11.12.1 Piramal Pharma Solutions Company Information &nbsp;11.12.2 Piramal Pharma Solutions New Chemical Entities (NCE) Product Offered &nbsp;11.12.3 Piramal Pharma Solutions New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 Piramal Pharma Solutions Main Business Overview &nbsp;11.12.5 Piramal Pharma Solutions Latest Developments &nbsp;11.13 Sai Life Sciences &nbsp;11.13.1 Sai Life Sciences Company Information &nbsp;11.13.2 Sai Life Sciences New Chemical Entities (NCE) Product Offered &nbsp;11.13.3 Sai Life Sciences New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 Sai Life Sciences Main Business Overview &nbsp;11.13.5 Sai Life Sciences Latest Developments &nbsp;11.14 Chempro Pharma &nbsp;11.14.1 Chempro Pharma Company Information &nbsp;11.14.2 Chempro Pharma New Chemical Entities (NCE) Product Offered &nbsp;11.14.3 Chempro Pharma New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 Chempro Pharma Main Business Overview &nbsp;11.14.5 Chempro Pharma Latest Developments &nbsp;11.15 LG Chem &nbsp;11.15.1 LG Chem Company Information &nbsp;11.15.2 LG Chem New Chemical Entities (NCE) Product Offered &nbsp;11.15.3 LG Chem New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.15.4 LG Chem Main Business Overview &nbsp;11.15.5 LG Chem Latest Developments &nbsp;11.16 Sofpromed &nbsp;11.16.1 Sofpromed Company Information &nbsp;11.16.2 Sofpromed New Chemical Entities (NCE) Product Offered &nbsp;11.16.3 Sofpromed New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.16.4 Sofpromed Main Business Overview &nbsp;11.16.5 Sofpromed Latest Developments &nbsp;11.17 Aurigene Pharmaceutical Services Ltd. &nbsp;11.17.1 Aurigene Pharmaceutical Services Ltd. Company Information &nbsp;11.17.2 Aurigene Pharmaceutical Services Ltd. New Chemical Entities (NCE) Product Offered &nbsp;11.17.3 Aurigene Pharmaceutical Services Ltd. New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.17.4 Aurigene Pharmaceutical Services Ltd. Main Business Overview &nbsp;11.17.5 Aurigene Pharmaceutical Services Ltd. Latest Developments &nbsp;11.18 Aragen Life Sciences Ltd &nbsp;11.18.1 Aragen Life Sciences Ltd Company Information &nbsp;11.18.2 Aragen Life Sciences Ltd New Chemical Entities (NCE) Product Offered &nbsp;11.18.3 Aragen Life Sciences Ltd New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.18.4 Aragen Life Sciences Ltd Main Business Overview &nbsp;11.18.5 Aragen Life Sciences Ltd Latest Developments &nbsp;11.19 WuXi AppTec &nbsp;11.19.1 WuXi AppTec Company Information &nbsp;11.19.2 WuXi AppTec New Chemical Entities (NCE) Product Offered &nbsp;11.19.3 WuXi AppTec New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.19.4 WuXi AppTec Main Business Overview &nbsp;11.19.5 WuXi AppTec Latest Developments &nbsp;11.20 PharmaBlock Sciences Nanjing Inc &nbsp;11.20.1 PharmaBlock Sciences Nanjing Inc Company Information &nbsp;11.20.2 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) Product Offered &nbsp;11.20.3 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.20.4 PharmaBlock Sciences Nanjing Inc Main Business Overview &nbsp;11.20.5 PharmaBlock Sciences Nanjing Inc Latest Developments 12 Research Findings and Conclusion

Report	Global New Chemical Entities (NCE) Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI8621

Buyer Information

Order Summary